Sodium-Glucose Co-Transporter-2 Inhibitors And Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data And Intriguing Clinical Decisions
mediaposted on 13.10.2020, 10:24 by Dimitrios Patoulias, Christodoulos Papadopoulos, Alexandra Katsimardou, Maria Toumpourleka, Michael Doumas
The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).